How is the Widal test interpreted for diagnosing typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Widal Test Interpretation for Diagnosing Typhoid Fever

The Widal test alone is not sufficient for diagnosing typhoid fever, as isolation of Salmonella typhi from blood, stool, or other clinical specimens is required for confirmation according to CDC guidelines. 1

Understanding the Widal Test

  • The Widal test is a serological test that detects agglutinating antibodies against O and H antigens of Salmonella Typhi and Paratyphi 2
  • It lacks sensitivity and specificity, especially in endemic areas where background antibody levels may be elevated 2
  • Blood culture remains the gold standard for diagnosis of typhoid fever, with highest yield within the first week of symptom onset 2

Interpretation Guidelines

Titer Thresholds

  • A single Widal test is generally considered positive when:
    • O agglutinin titers ≥1:200 or H agglutinin titers ≥1:200 3, 4
    • In some endemic regions, O or H agglutinin titers ≥1:320 may be considered more specific 5

Improving Diagnostic Value

  • A four-fold or greater rise in antibody titer between acute and convalescent samples (taken 7-10 days apart) significantly improves diagnostic accuracy 3
  • When performed on convalescent-phase serum, sensitivity increases to 90% with 90% specificity 3

Limitations of the Widal Test

  • Serologic evidence alone is not sufficient for diagnosis according to CDC guidelines 1
  • False positives may occur due to:
    • Cross-reactions with other Salmonella species
    • Previous typhoid vaccination
    • Prior typhoid infection
    • Other febrile illnesses 2
  • False negatives may occur due to:
    • Early testing (first week of illness)
    • Prior antibiotic treatment
    • Immunosuppression 4

Regional Considerations

  • Background antibody levels vary by region, affecting interpretation:
    • In endemic areas, higher cutoff titers may be necessary 5
    • In non-endemic areas, lower titers may have greater significance 6
  • Regional studies have found varying optimal cutoff values:
    • Turkey: O and H agglutinin titers ≥1:200 3
    • West Africa: O and H agglutinin titers ≥1:80 4
    • South Africa: O or H agglutinin titers ≥1:200 6

Diagnostic Algorithm

  1. Consider clinical presentation consistent with typhoid fever:

    • Sustained fever, headache, malaise, anorexia, relative bradycardia, constipation or diarrhea, and nonproductive cough 1
  2. Obtain blood cultures (gold standard):

    • Highest yield within first week of symptoms 2
    • May remain negative in 87.5-95% of cases 1
  3. Interpret Widal test results:

    • Single test: O or H agglutinin titers ≥1:200 suggest possible typhoid fever 3, 6
    • Paired samples: Four-fold or greater rise in titer is more reliable 3
  4. Consider alternative diagnostic tests:

    • Newer rapid serological tests may have better performance characteristics 7
    • TPTest has shown higher sensitivity (96.0%) and specificity (96.6%) compared to Widal test in endemic settings 7

Common Pitfalls

  • Relying solely on a single Widal test for diagnosis 4
  • Using inappropriate cutoff values for the specific geographic region 5, 6
  • Failing to consider vaccination history when interpreting results 2
  • Not confirming diagnosis with blood culture when possible 1
  • Misinterpreting results in endemic areas where background titers may be elevated 2

Remember that according to CDC guidelines, isolation of S. typhi from blood, stool, or other clinical specimens is required for confirmation of typhoid fever, and serologic evidence alone is not sufficient for diagnosis 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Widal Test Positive Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Widal test in diagnosis of typhoid fever in Turkey.

Clinical and diagnostic laboratory immunology, 2002

Research

Widal agglutination titres in the diagnosis of typhoid fever.

West African journal of medicine, 2007

Research

The Widal test in the diagnosis of typhoid fever in the transvaal.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.